)
Edge
Extra Everything: The Story of Chipotle
Chipotle's story from a single restaurant to a nationwide chain, through crisis and turnaround, built on one of the strongest models in the industry.
Bloomage BioTechnology
Bloomage BioTechnology (688363) investor relations material
Bloomage BioTechnology Q1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 2026 earnings summary30 Apr, 2026
Executive summary
Revenue for Q1 2026 was RMB 829.41 million, down 23.06% year-over-year; net profit attributable to shareholders was RMB 64.65 million, down 36.55% year-over-year.
Decline in profit mainly due to lower revenue from skin science innovation and transformation business and strategic investments for future growth.
Operating cash flow turned positive to RMB 130.96 million, reflecting improved operational efficiency and cost control.
Company is undergoing strategic restructuring, focusing on synthetic biology, AI integration, and high-quality development.
Financial highlights
Operating income: RMB 829.41 million, down 23.06% year-over-year.
Net profit attributable to shareholders: RMB 64.65 million, down 36.55% year-over-year.
Operating cash flow: RMB 130.96 million, a significant improvement from negative RMB 22.98 million last year.
Basic and diluted EPS: RMB 0.14, down 33.33% year-over-year.
R&D investment: RMB 85.79 million, accounting for 10.34% of revenue.
Outlook and guidance
Company aims to drive growth through synthetic biology and AI, focusing on anti-aging and tissue regeneration.
Strategic restructuring expected to yield higher quality growth and improved product logic.
Anticipates new growth cycle as production capacity and brand/product upgrades are completed.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Bloomage BioTechnology
- Net profit jumped 67.59% despite a 21.82% revenue drop, driven by margin and cost improvements.688363
Q4 202523 Apr 2026 - Revenue and profit fell sharply amid strategic transformation and increased costs.688363Q4 202424 Dec 2025
- Q3 net profit surged 55.63% year-over-year as operational quality and cash flow improved.688363Q3 202529 Oct 2025
- Revenue and net profit declined sharply, but R&D and core margins remained strong.688363Q2 202527 Aug 2025
- Q3 net profit plunged 77% year-over-year on lower sales and higher expenses.688363Q3 202413 Jun 2025
- H1 2024 saw profit decline but strong growth in medical terminals and raw materials.688363Q2 202413 Jun 2025
- Q1 profit fell 58% on weak skin science sales; strategic upgrades and R&D investment continue.688363Q1 20256 Jun 2025
Next Bloomage BioTechnology earnings date
Q2 202625 Aug, 2026
Bloomage BioTechnology
Next Bloomage BioTechnology earnings date
Q2 202625 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
)
Frequently asked questions
Explore our global coverage